Clinical trial
The Efficacy of Ultra-High-Resolution Mapping Guided Partial Antral Ablation for Atrial Fibrillation
NCT03759912 is registered in ClinicalTrials.gov with Keimyung University Dongsan Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Efficacy of Ultra-High-Resolution Mapping Guided Partial Antral Ablation for Atrial Fibrillation
- Lead sponsor
- Keimyung University Dongsan Medical Center
- Phase
- Observational
- Overall status
- Terminated
- Start date
- November 20, 2018
- Completion date
- August 7, 2021
- Enrollment
- 75 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.